Endogenous factor VIII synthesis from the intron 22-inverted F8 locus may modulate the immunogenicity of replacement therapy for hemophilia AGouri Shankar PandeyChen Yanoveret al.2013Nature Medicine
The intron-22-inverted F8 locus permits factor VIII synthesis: Explanation for low inhibitor risk and a role for pharmacogenomicsZuben E. SaunaJay N. Lozieret al.2015Blood
Polymorphisms in the F8 Gene and MHC-II Variants as Risk Factors for the Development of Inhibitory Anti-Factor VIII Antibodies during the Treatment of Hemophilia A: A Computational AssessmentGouri Shankar PandeyChen Yanoveret al.2013PLoS Computational Biology